Brett Goldsmith

Ph.D., Co-Founder and CTO
Cardea Bio, Inc.

Dr. Brett Goldsmith is the Co-founder and CTO of Cardea Bio, Inc. His passion is applying nanoelectronics technology to products that change people’s lives. Previous to Cardea, Brett was a post-doc at the University of Pennsylvania, an Intelligence Community Fellow and is the lead researcher on landmark Field Effect Biosensing papers in Science and Nature Nanotechnology.

Share page with AddThis